Marijuana for Medical Professionals Conference 2 - November 14th, 15th and 16th, 2016
Cannabinoids as potential anticancer agents

Clinical Application of Cannabinoids and Terpenes

For over five years, Ms Gordon has been collecting cannabis patient data using specific dosing protocols across a myriad of diseases. These patients have been tracked for efficacy utilizing various qualitative and quantitative techniques. Discussion includes case studies, including outcomes.

The Endocannabinoid System: Looking Back and Ahead

In the 1960's, a young researcher in Israel named Raphael Mechoulam isolated THC tetrahydrocannabinol from cannabis and explained the mechanism of activity - and psychoactivity - of the plant. A lifetime of achievements in science followed. Who better to lead us into the future of cannabinoid science than Mechoulam himself? Now in his late 80's, the tireless Professor speaks to us live, via Skype.

Cancer, Hematopoietic Stem Cell Transplantation, and Cannabis

University of Colorado alumnus Reuven Or MD, PhD returns to our beloved Rocky Mountains to share his work with us. Dr Or's team at Hadassah University Medical Center in Jerusalem, Israel has lead the world in new therapy models for improving bone marrow transplantation outcomes. The role of cannabis in the immune system, and how that applies to transplant therapies is a session not to be missed.